Abstract
Objective: To demonstrate the sensitivity of a recently developed whole-brain magnetic resonance spectroscopic imaging (MRSI) sequence to cerebral pathology and disability in amyotrophic lateral sclerosis (ALS), and compare with measures derived from diffusion tensor imaging. Methods: Whole-brain MRSI and diffusion tensor imaging were undertaken in 13 patients and 14 age-similar healthy controls. Mean N-acety laspartate (NAA), fractional anisotropy, and mean diffusivity were extracted from the corticospinal tract, compared between groups, and then in relation to disability in the patient group. Results: Significant reductions in NAA were found along the course of the corticospinal tracts on whole-brain MRSI. There were also significant changes in fractional anisotropy (decreased) and mean diffusivity (increased) in the patient group, but only NAA showed a significant relationship with disability (r = 0.65, p = 0.01). Conclusion: Whole-brain MRSI has potential as a quantifiable neuroimaging marker of disability in ALS. It offers renewed hope for a neuroimaging outcome measure with the potential for harmonization across multiple sites in the context of a therapeutic trial.
| Original language | English |
|---|---|
| Pages (from-to) | 610-615 |
| Number of pages | 6 |
| Journal | Neurology |
| Volume | 80 |
| Issue number | 7 |
| DOIs | |
| State | Published - Feb 12 2013 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
- Arts and Humanities (miscellaneous)
Cite this
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. / Stagg, Charlotte J.; Knight, Steven; Jenkinson, Mark; Maudsley, Andrew A; Turner, Martin R.
In: Neurology, Vol. 80, No. 7, 12.02.2013, p. 610-615.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS
AU - Stagg, Charlotte J.
AU - Knight, Steven
AU - Jenkinson, Mark
AU - Maudsley, Andrew A
AU - Turner, Martin R.
PY - 2013/2/12
Y1 - 2013/2/12
N2 - Objective: To demonstrate the sensitivity of a recently developed whole-brain magnetic resonance spectroscopic imaging (MRSI) sequence to cerebral pathology and disability in amyotrophic lateral sclerosis (ALS), and compare with measures derived from diffusion tensor imaging. Methods: Whole-brain MRSI and diffusion tensor imaging were undertaken in 13 patients and 14 age-similar healthy controls. Mean N-acety laspartate (NAA), fractional anisotropy, and mean diffusivity were extracted from the corticospinal tract, compared between groups, and then in relation to disability in the patient group. Results: Significant reductions in NAA were found along the course of the corticospinal tracts on whole-brain MRSI. There were also significant changes in fractional anisotropy (decreased) and mean diffusivity (increased) in the patient group, but only NAA showed a significant relationship with disability (r = 0.65, p = 0.01). Conclusion: Whole-brain MRSI has potential as a quantifiable neuroimaging marker of disability in ALS. It offers renewed hope for a neuroimaging outcome measure with the potential for harmonization across multiple sites in the context of a therapeutic trial.
AB - Objective: To demonstrate the sensitivity of a recently developed whole-brain magnetic resonance spectroscopic imaging (MRSI) sequence to cerebral pathology and disability in amyotrophic lateral sclerosis (ALS), and compare with measures derived from diffusion tensor imaging. Methods: Whole-brain MRSI and diffusion tensor imaging were undertaken in 13 patients and 14 age-similar healthy controls. Mean N-acety laspartate (NAA), fractional anisotropy, and mean diffusivity were extracted from the corticospinal tract, compared between groups, and then in relation to disability in the patient group. Results: Significant reductions in NAA were found along the course of the corticospinal tracts on whole-brain MRSI. There were also significant changes in fractional anisotropy (decreased) and mean diffusivity (increased) in the patient group, but only NAA showed a significant relationship with disability (r = 0.65, p = 0.01). Conclusion: Whole-brain MRSI has potential as a quantifiable neuroimaging marker of disability in ALS. It offers renewed hope for a neuroimaging outcome measure with the potential for harmonization across multiple sites in the context of a therapeutic trial.
UR - http://www.scopus.com/inward/record.url?scp=84875836525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875836525&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e318281ccec
DO - 10.1212/WNL.0b013e318281ccec
M3 - Article
C2 - 23325907
AN - SCOPUS:84875836525
VL - 80
SP - 610
EP - 615
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 7
ER -